@article {Baral2021.07.14.21260549, author = {Nischit Baral and Nirajan Nayak}, title = {Influenza infection, Acute myocardial Infarction, Flu Shot during COVID-19 Pandemic in US population. A Review of Literature}, elocation-id = {2021.07.14.21260549}, year = {2021}, doi = {10.1101/2021.07.14.21260549}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Influenza is a major cause of hospitalization in all age groups but can cause more severe infections in specific high-risk population. Novel Corona Virus Disease 2019 (COVID-19) pandemic and Influenza virus infection cause similar illness and coexist. Cardiovascular complications due to influenza are important causes of morbidity and mortality in the US, especially in the elderly population (aged more than 65 years). Acute Myocardial Infarction (AMI) is the most serious among the cardiovascular causes of mortality following the attack of influenza, mainly in patients with various co-morbidities like pre-existing coronary artery disease (CAD), diabetes mellitus (DM), hypertension (HTN), and heart failure (HF). We have reviewed the association between influenza virus infection and AMI and extrapolated the beneficial effects of influenza vaccine in preventing AMI and its grave consequences. We have also highlighted about the importance of flu shot during the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot registered as this is review article.Funding StatementNONEAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:As this is a literature review, IRB is not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPlease email at baralnis{at}msu.edu}, URL = {https://www.medrxiv.org/content/early/2021/07/30/2021.07.14.21260549}, eprint = {https://www.medrxiv.org/content/early/2021/07/30/2021.07.14.21260549.full.pdf}, journal = {medRxiv} }